Preclinical development of gene therapy products for muscular dystrophies.

Orphan Drugs & Rare Diseases Global Congress Europe 2025 · 19 March 2025 · 14:15 · Auditorium 1

Preclinical development of gene therapy products for muscular dystrophies. was a session at Orphan Drugs & Rare Diseases Global Congress Europe 2025 on 19 March 2025 in London, with 1 speaker on record.

Speakers

• Dr Alberto Malerba — Speaker Lecturer in Gene therapy, Gene Medicine Laboratory for Rare Diseases, Royal Holloway, University of London